What we know Some human studies demonstrate that pantethine effectively lowers total-cholesterol, LDL-C, and triglyceride levels, and raises HDL-cholesterol in individuals who have diabetes and abnormal blood lipids
To learn more, find us at vioscompounding.com #CompoundingPharmacy #PersonalizedMedicine #BiohackingHealth #OptimizeYourHealth #precisionmedicine Open Most people think declining strength, joint discomfort, and slower recovery are just part of getting older
Weight loss injections are expensive, and NHS availability is limited to specific circumstances meeting NICE criteria
The SUSTAIN trial program documents a lower injection site reaction rate with semaglutide than with earlier GLP-1 agents, per data published in The Lancet Diabetes and Endocrinology
It works by mimicking the GLP-1 hormone to increase insulin secretion, decrease glucagon release, and slow gastric emptying
Extending a tier to six or eight weeks while GI symptoms stabilize is clinically sensible and does not compromise long-term outcomes